Seminars in Oncology Nursing
Volume 24, Issue 1 , Pages 57-67 , February 2008

Supportive Care in Lung Cancer

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66
  2. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. v.1.2007. Palliative care. Available at: http://www.nccn.org/professionals/physician_gls/PDF/palliative.pdf (accessed Dec 18, 2007).
  3. Cooley ME. Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage. 2000;19:137–153
  4. Fox SW, Lyon DE. Symptom clusters and quality of life in survivors of lung cancer. Oncol Nurs Forum. 2006;33:931–936
  5. Chan CW, Richardson A, Richardson J. A study to assess the existence of the symptom cluster of breathlessness, fatigue and anxiety in patients with advanced lung cancer. Eur J Oncol Nurs. 2005;9:325–333
  6. Gift AG, Stommel M, Jablonski A, Given W. A cluster of symptoms over time in patients with lung cancer. Nurs Res. 2003;52:393–400
  7. Gift AG, Jablonski A, Stommel M, et al. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31:202–212
  8. Mitchell SA, Beck SL, Hood LE, et al. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs. 2007;11:99–113
  9. Kim Y, Hickok JT, Morrow G. Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach. J Pain Symptom Manage. 2006;32:311–321
  10. Munch TN, Stromgren AS, Pedersen L, et al. Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the multidimensional fatigue inventory. J Pain Symptom Manage. 2006;31:533–541
  11. Tanaka K, Akechi T, Okuyama T, et al. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002;23:417–423
  12. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. v.4.2007. Cancer-related fatigue. Available at: www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf (accessed Dec 18, 2007).
  13. Johnston MP, Coward DD. Cancer-related fatigue: nursing assessment and management: increasing awareness of the effect of cancer-related fatigue. Am J Nurs. 2001;101(suppl):19–22
  14. Kaasa S, Loge JH, Knobel H, et al. Fatigue. Measures and relation to pain. Acta Anaesthesiol Scand. 1999;43:939–947
  15. Cella DF, Bonomi AE, Lloyd SR, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer. 1995;12:199–220
  16. Hollen PJ, Gralla RJ, Kris MG, et al. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer. 1993;29A(suppl 1):S51–S58
  17. Mendoza T, Wang X, Cleeland C, et al. The rapid assessment of fatigue severity in cancer patients. Cancer. 1999;85:1186–1196
  18. Stricker CT, Drake D, Hoyer KA, et al. Evidence-based practice for fatigue management in adults with cancer: exercise as an intervention. Oncol Nurs Forum. 2004;31:963–976
  19. Barsevick AM, Dudley W, Beck S, et al. A randomized clinical trial of energy conservation for patients with cancer-related fatigue. Cancer. 2004;100:1302–1310
  20. Nail LM. Fatigue in patients with cancer. Oncol Nurs Forum. 2002;29:537–546
  21. Morrow GR, Shelke AR, Roscoe JA, et al. Management of cancer-related fatigue. Cancer Invest. 2005;23:229–239
  22. Beach P, Siebeneck B, Buderer NF, et al. Relationship between fatigue and nutritional status in patients receiving radiation therapy to treat lung cancer. Oncol Nurs Forum. 2001;28:1027–1031
  23. Yang YH. Relationship between fatigue and nutritional status in patients with cancer undergoing radiotherapy. Taehan Kanho Hakhoe Chi. 2003;33:478–487
  24. Gramignano G, Lusso MR, Madeddu C, et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition. 2006;22:136–145
  25. Wells M, Sarna L, Cooley ME, et al. Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs. 2007;30:45–55
  26. Administration USFaD. Information on erythropoiesis stimulating agents (ESA). Available at: http://fda.gov/cder/drug/infopage?RHE/default.htm. (accessed Dec 18, 2007).
  27. Barnes EA, Bruera E. Fatigue in patients with advanced cancer: a review. Int J Gynecol Cancer. 2002;12:424–428
  28. Hopwood P, Stephens RJ. Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer. 1995;71:633–636
  29. Dudgeon DJ, Kristjanson L, Sloan JA, et al. Dyspnea in cancer patients: Prevalence and associated factors. J Pain Symptom Manage. 2001;2195–2102
  30. Ripimonti C, Fusco F. Respiratory problems in supportive care. Cancer. 2002;10:204–216
  31. Brown ML, Carrieri V, Janson B, et al. Lung cancer and dyspnea: the patient's perception. Oncol Nurs Forum. 1986;13:19–24
  32. O'Driscoll M, Corner J, Bailey C. The experience of breathlessness in lung cancer. Eur J Cancer Care (Engl). 1999;8:37–43
  33. American Thoracic Society . Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321–340
  34. Dudley DL, Martin CJ, Holmes TH. Psychophysiologic studies of pulmonary ventilation. Psychosom Med. 1964;26:645–660
  35. Gift AG. Psychologic and physiologic aspects of acute dyspnea in asthmatics. Nurs Res. 1991;40:196–199
  36. Smith EL, Hann DM, Ahles TA, et al. Dyspnea, anxiety, body consciousness, and quality of life in patients with lung cancer. J Pain Symptom Manage. 2001;21:323–329
  37. Chetta A, Gerra G, Foresi A, et al. Personality profiles and breathlessness perception in outpatients with different gradings of asthma. Am J Respir Crit Care Med. 1998;157:116–122
  38. Joyce M, Beck SL. Measuring oncology nursing-sensitive patient outcomes: evidence based summary. Available at: http://onsopcontent.ons.org/toolkits/evidence/Clinical/pdf/DyspneaTools.pdf (accessed July 24, 2005).
  39. Houlihan NG, Inzeo D, Joyce M, et al. Symptom management of lung cancer. Clin J Oncol Nurs. 2004;8:645–652
  40. Bruera E, de Stoutz N, Velasco-Leiva A, et al. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet. 1993;342:13–14
  41. Bruera E, Sweeney C, Willey J, et al. A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med. 2003;17:659–663
  42. Dudgeon DJ. Managing dyspnea and cough. Hematol Oncol Clin North Am. 2002;16:557–577
  43. Jennings AL, Davies AN, Higgins JP, et al. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939–944
  44. Allard P, Lamontagne C, Bernard P, et al. How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage. 1999;17:256–265
  45. Joyce M, McSweeney M, Carrieri-Kohlman VL, et al. The use of nebulized opioids in the management of dyspnea: evidence synthesis. Oncol Nurs Forum. 2004;31:551–561
  46. Coyne PJ, Viswanathan R, Smith TJ. Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea. J Pain Symptom Manage. 2002;23:157–160
  47. Kohara H, Ueoka H, Aoe K, et al. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. J Pain Symptom Manage. 2003;26:962–967
  48. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin. 2004;20:403–417
  49. Ripamonti C. Management of dyspnea in advanced cancer patient. Support Care Cancer. 1999;7:233–243
  50. Bredin M, Corner J, Krishnasamy M, et al. Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ. 1999;318:901–904
  51. Kvale PA, Simoff M, Prakash UB. Palliative care. Chest. 2003;123:284S–311S
  52. Tyson LB. Cough. In:  Camp-Sorrell D,  Hawkins R editor. Clinical manual for the oncology advanced practice nurse. Ed 2.. Pittsburgh, PA: Oncology Nursing Society; 2006;p. 147–151
  53. Potter J, Higginson IJ. Pain experienced by lung cancer patients: a review of prevalence, causes and pathophysiology. Lung Cancer. 2004;43:247–257
  54. Silvestri GA, Sherman C, Williams T, et al. Caring for the dying patient with lung cancer. Chest. 2002;122:1028–1036
  55. Miaskowski C, Cleary J, Burney R, et al. Guideline for the management of cancer pain in adults and children. Glenview, IL: American Pain Society; 2004;
  56. Cheran SK, Herndon JE, Patz EF. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer. 2004;44:317–325
  57. Pinover W, Coia L. Palliative radiation therapy. In:  Berger AM,  Portenoy R,  Weissman D editor. Principles and practice of supportive oncology. Philadelphia, PA: Lippincott-Raven; 1998;p. 603–626
  58. Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial–the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol. 2003;21:3150–3157
  59. Bukowski R, Rosen L, Gordon D, et al. Long-term therapy with zoledronic acid is effective and safe in reducing the risk of skeletal complications in patients with bone metastases from non-small cell lung cancer. Lung Cancer. 2003;41(suppl 2):S262–S263
  60. Ginsberg R, Payne D, Shamji F. Superior sulcus tumors. In:  Aisner J,  Arriagada R,  Green M,  Martini N,  Perry M editor. Comprehensive textbook of thoracic oncology. Baltimore, MD: Williams &Wilkins; 1996;p. 375–387
  61. Guerrero M, Williams S. Pancoast tumor. E-Medicine. 2004;Available at: http://www.emedicine.com/radio/topic515.htm(accessed March 23, 2007)
  62. Klastersky J. Supportive care in cancer patients. In:  Aisner J,  Arriagada R,  Green M,  Martini N,  Perry M editor. Comprehensive textbook of thoracic oncology. Baltimore, MD: Williams & Wilkins; 1996;p. 980–1001
  63. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69:491–497
  64. Bozzetti F. Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition. 2002;18:953–959
  65. Linn BS, Robinson DS, Klimas NG. Effects of age and nutritional status on surgical outcomes in head and neck cancer. Ann Surg. 1988;207:267–273
  66. Nguyen TV, Yueh B. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer. 2002;95:553–562
  67. Haugstvedt TK, Viste A, Eide GE, et al. Factors related to and consequences of weight loss in patients with stomach cancer. The Norwegian Multicenter experience. Norwegian Stomach Cancer Trial. Cancer. 1991;67:722–729
  68. Milstein D, Sapir D, Cohen Y, et al. Prognostic factors in patients with lung cancer. Isr J Med Sci. 1988;24:588–592
  69. Barber M. The pathophysiology and treatment of cancer cachexia. Nutr Clin Pract. 2002;17:203–209
  70. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer. 2002;2:862–871
  71. Lind D, Souba W, Copeland E. Weight loss and cachexia. In:  Abeloff M,  Armitage J,  Lichter A,  Niederhuber J editor. Clinical oncology. New York, NY: Churchill Livingstone; 1995;p. 393–407
  72. Cohn S, Sawitsky A, Vartsky D. In vivo quantification of body nitrogen and body composition in cancer patients and cancer nutrition studies. Nutr Cancer. 1980;2:67–71
  73. Cohn S, Ellis K, Vartsky D. Comparison of methods of estimating body fat in normal subjects and cancer patients. Am J Clin Nutr. 1981;34:2839–2847
  74. Cohn S, Gartenhaus W, Sawitsky A. Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water. Metabolism. 1981;30:222–229
  75. Cohn S, Gartenhaus W, Vartsky D. Body composition and dietary intake in neoplastic disease. Am J Clin Nutr. 1981;34:1997–2004
  76. Cohn S, Vaswani A, Vartsky D. In vivo quantification of body nitrogen for nutritional assessment. Am J Clin Nutri. 1982;35:1186–1191
  77. Shizgal HM. Body composition of patients with malnutrition and cancer. Summary of methods of assessment. Cancer. 1985;55(suppl):250–253
  78. May P, Barber A, D'Olimpio J, et al. Reversal of cancer related wasting using oral supplementation with a combination of B-hydroxy-B-methylbutyrate, arginine, adn glutamine. Am J Surg. 2002;183:471–479
  79. Marian M. Cancer cachexia: prevalence, mechanisms, and interventions. Support Line. 1998;20:3–12
  80. Capra S, Ferguson M, Ried K. Cancer: impact of nutrition intervention outcome–nutrition issues for patients. Nutrition. 2001;17:769–772
  81. Ovesen L, Allingstrup L, Hannibal J, et al. Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol. 1993;11:2043–2049
  82. In:  McCallum PD,  Elliott L,  Molseed L,  Grant B editor. The clinical guide to oncology nutrition. Chicago, IL: American Dietetic Association; 2006;
  83. Brown JK. A systematic review of the evidence on symptom management of cancer-related anorexia and cachexia. Oncol Nurs Forum. 2002;29:517–532
  84. Zabora J, Brintzenhofeszoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10:19–28
  85. Faller H, Schilling S, Lang H. Causal attribution and adaptation among lung cancer patients. J Psychosomatic Res. 1995;39:619–627
  86. Walker MS, Zona DM, Fisher EB. Depressive symptoms after lung cancer surgery: Their relation to coping style and social support. Psychooncology. 2006;15:684–693
  87. Sarna L, Evangelista L, Tashkin D, et al. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004;125:439–445
  88. Miller K, Massie MJ. Depression and anxiety. Cancer J. 2006;12:388–397

PII: S0749-2081(07)00142-8

doi: 10.1016/j.soncn.2007.11.013

Seminars in Oncology Nursing
Volume 24, Issue 1 , Pages 57-67 , February 2008

Article Tools